YM
Therapeutic Areas
BioLight Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TeaRx™ | Dry eye and ocular surface disease diagnosis | Pre‑clinical/early clinical |
| Ocular D | Dry eye and digital eye strain | Commercial (CE‑approved) |
| Eye‑D implant | Glaucoma | Phase I/II completed, preparing for Phase III |
| Nanostructure drug platform | Various ocular diseases | Pre‑clinical |
| Peripheral Vision Monitoring | Glaucoma and peripheral vision impairment | Commercial |
| AI retinal disease platform | Retinal diseases (AMD, diabetic retinopathy, etc.) | Pre‑clinical/early clinical |
| TRS 01 | Uveitis with high intra‑ocular pressure | Pre‑clinical |
| Fast laser device | Glaucoma IOP reduction | Commercial |